BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 24438192)

  • 1. Serum pentraxin 3 concentrations in neonates.
    Lannergård A; Rosenström F; Normann E; Larsson A
    Ups J Med Sci; 2014 Mar; 119(1):62-4. PubMed ID: 24438192
    [No Abstract]   [Full Text] [Related]  

  • 2. Relationship between pentraxin 3 levels of the mothers with preterm premature rupture of membranes and their neonates.
    Agilli M; Aydin FN; Kurt YG; Cayci T
    J Matern Fetal Neonatal Med; 2015; 28(17):2040. PubMed ID: 25357242
    [No Abstract]   [Full Text] [Related]  

  • 3. Pentraxin 3 in neonates with and without diagnosis of pulmonary hypertension.
    Farhadi R; Rafiei A; Hamdamian S; Zamani H; Yazdani J
    Clin Biochem; 2017 Mar; 50(4-5):223-227. PubMed ID: 27838407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased serum pentraxin-3 levels; a novel cardiovascular marker.
    Varol E
    Turk Kardiyol Dern Ars; 2013 Jun; 41(4):296-8. PubMed ID: 23760116
    [No Abstract]   [Full Text] [Related]  

  • 5. Pentraxin 3 concentrations of the mothers with preterm premature rupture of membranes and their neonates, and early neonatal outcome.
    Akin MA; Gunes T; Coban D; Ozgun MT; Akgun H; Kurtoglu S
    J Matern Fetal Neonatal Med; 2015 Jul; 28(10):1170-5. PubMed ID: 25048752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pentraxin 3 (PTX3) plasma levels and carotid intima media thickness progression in the general population: a methodological approach.
    Agilli M; Aydin FN; Cayci T; Kurt YG
    Nutr Metab Cardiovasc Dis; 2014 Dec; 24(12):e38-9. PubMed ID: 25304608
    [No Abstract]   [Full Text] [Related]  

  • 7. Is pentraxin 3 a cardiovascular marker in patients with chronic Chagas disease?
    Lidani KC; Beltrame MH; Luz PR; Sandri TL; Nisihara RM; de Messias-Reaso IJ
    Int J Cardiol; 2015; 190():233-5. PubMed ID: 25920034
    [No Abstract]   [Full Text] [Related]  

  • 8. Pentraxin 3 values during normal pregnancy.
    Larsson A; Palm M; Helmersson J; Axelsson O
    Inflammation; 2011 Oct; 34(5):448-51. PubMed ID: 20852923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pentraxin 3 is useful to differentiate infections from flares in patients with systemic lupus erythematosus who present systemic inflammatory response.
    Aragón CC; Nieto-Aristizábal I; Ríos-Serna LJ; Barrera MC; Naranjo-Escobar J; Posso-Osorio I; Lara-Erazo V; Leib P; Moreno-Angarita A; Aguirre-Valencia D; Echeverri A; Cañas CA; Tobón GJ
    Lupus; 2019 Sep; 28(10):1279-1280. PubMed ID: 31446881
    [No Abstract]   [Full Text] [Related]  

  • 10. Increased expression of long pentraxin PTX3 in inflammatory bowel diseases.
    Kato S; Ochiai M; Sakurada T; Ohno S; Miyamoto K; Sagara M; Ito M; Takeuchi K; Imaki J; Itoh K; Yakabi K
    Dig Dis Sci; 2008 Jul; 53(7):1910-6. PubMed ID: 17990107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pentraxin-3 is a candidate biomarker on the spectrum of severity from pre-eclampsia to HELLP syndrome: GenPE study.
    Colmenares-Mejía CC; Quintero-Lesmes DC; Bautista-Niño PK; Guio Mahecha E; Beltrán Avendaño M; Díaz Martínez LA; Ortiz Serrano R; Páez Leal MC; Monterrosa Castro Á; Mesa Restrepo CM; Monsalve G; Sanín-Blair E; Saldarriaga W; Luna ML; Casas JP; Serrano Díaz N
    Hypertens Res; 2020 Sep; 43(9):884-891. PubMed ID: 32284540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pentraxin 3 as a novel diagnostic marker in neonatal sepsis.
    Fahmey SS; Mostafa N
    J Neonatal Perinatal Med; 2019; 12(4):437-442. PubMed ID: 31381534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pentraxin-3 as a local inflammatory marker in chronic spontaneous urticaria.
    Kasperska-Zajac A; Grzanka A; Misiolek M; Mazur B; Machura E
    Cytokine; 2015 Dec; 76(2):566-568. PubMed ID: 25982553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of pentraxin-3 in POEMS syndrome.
    Agilli M; Aydin FN
    J Neuroimmunol; 2015 Jan; 278():136. PubMed ID: 25595262
    [No Abstract]   [Full Text] [Related]  

  • 15. Pentraxin-3.
    Akaike M
    Circ J; 2014; 78(1):65-6. PubMed ID: 24284958
    [No Abstract]   [Full Text] [Related]  

  • 16. The Basic Characteristics of the Pentraxin Family and Their Functions in Tumor Progression.
    Wang Z; Wang X; Zou H; Dai Z; Feng S; Zhang M; Xiao G; Liu Z; Cheng Q
    Front Immunol; 2020; 11():1757. PubMed ID: 33013829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pentraxin 3 as a new biomarker of diastolic dysfunction.
    Liu Q; Tu T; Bai Z; Zhou S
    Int J Cardiol; 2011 Oct; 152(1):106-7. PubMed ID: 21855152
    [No Abstract]   [Full Text] [Related]  

  • 18. Pentraxin 3 innately preps damaged tissue for wound healing.
    Rua R; McGavern DB
    J Exp Med; 2015 Jun; 212(6):829. PubMed ID: 26034115
    [No Abstract]   [Full Text] [Related]  

  • 19. Childhood obesity, metabolic syndrome and Pentraxin-3.
    Menon PS
    Indian J Pediatr; 2015 Jan; 82(1):3-4. PubMed ID: 25502797
    [No Abstract]   [Full Text] [Related]  

  • 20. Arterial stiffness and pentraxin 3 levels in obese patients.
    Balta S; Kurtoglu E; Ozturk C; Demırkol S; Demır M
    Am J Hypertens; 2014 Jun; 27(6):881. PubMed ID: 24610886
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.